NCT06102395 2023-10-30Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCCBeijing Tongren HospitalPhase 3 Recruiting272 enrolled